quirogad.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

NIH indirects case update: Hearing ongoing now, and I'll try to live tweet some notable exchanges. Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides: (I'm paraphrasing here)

submitted 8 days ago • 16 comments

Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j @drgattimays.bsky.social @veredstearns.bsky.social

submitted 17 days ago • 0 comments

In Ohio during FY23 (2022-2023) this was the impact of NIH funding: $1.01 Billion in grants and contracts $2.05 Billion in economic support 13,061 jobs supported This reduction in NIH indirect will decimate research and limit health care advances www.unitedformedicalresearch.org/nih-in-your-...

submitted 21 days ago • 0 comments

1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...

submitted 21 days ago • 270 comments

Great session with Dr Heather McArthur on treating early stage #TNBC #IO posted on #ReachMD @osuwexmed.bsky.social @osucccjames.bsky.social reachmd.com/programs/cme...

submitted 22 days ago • 1 comment

200 participants at OSU SABCS meeting - Christian Rolfo @christianrolfo.bsky.social @stoverlab.bsky.social @quirogad.bsky.social oncodaily.com/blog/237555 #BreastCancer #Cancer #FightAgainstCancer #MedOnc #OncoDaily #Oncology #OSU #SABCSmeeting #Medicine #Health

submitted 25 days ago • 0 comments

Dr. Quiroga, we're delighted to have you on the expert panel and look forward to your presentation on immunotherapy for late-stage breast cancer!

submitted 26 days ago • 0 comments

Happy to share our retrospective study on #pneumonitis risk in patients with #breastcancer who receive #TDXd #Enhertu @stoverlab.bsky.social @osucccjames.bsky.social #bcsm

submitted 25 days ago • 1 comment

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

submitted 26 days ago • 1 comment

🎉Reunion w/ my co-fellow @jasminesukumar.bsky.social @mdanderson.bsky.social to discuss early #breastcancer adj tx w/ path germline muts on the @ascocancer.bsky.social Daily News podcast 👉Who needs testing? 👉OLYMPIA updates 👉Concurrent PARPi use w/ other adj tx ascodaily.libsyn.com/advances-in-...

submitted 26 days ago • 0 comments

📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th! A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits @sitcancer.bsky.social #LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social

submitted 27 days ago • 0 comments

OSU SABCS meeting - 200 participants in attendance. Great turn out and awesome presentations by our amazing Breast Cancer team. Very proud of them 🙂👏 @OhioStateMedOnc @StoverLab @quirogad @CherianMathew30 Maggie Gatti-Myes and all team! #SABCS24 @OSUCCC_James @OhioStateMed

submitted 27 days ago • 0 comments

Love working with this group of talented docs! (We are so in sync we color coordinated without planning it #ScarletandGrey) @osucccjames.bsky.social

submitted 27 days ago • 0 comments

Great segment on @nbc4i.bsky.social by @stoverlab.bsky.social @osucccjames.bsky.social on the recent #ACS cancer stats www.nbc4i.com/video/annual...

submitted 37 days ago • 0 comments

⏱️ The next cancer cure is on hold. ⁦‪@NIH‬⁩ grants invest in future science gains that pay back for our citizens at a rate of more than 2:1 in economic activity. We are losing the battle for discovery.

submitted 37 days ago • 2 comments

Excellent advocacy program with Living Beyond Breast Cancer (LBBC) specific to patients living with stage IV/metastatic disease! This program was the foundation for my advocacy work and you'll meet some pretty amazing peeps along the way as well ♥️ bit.ly/3tEqyP9

submitted 46 days ago • 0 comments

Looking for your first faculty position? Or perhaps new start? THE Ohio State University Comprehensive Cancer Center (Columbus, OH) is hiring in several #MedOnc sections - GI, Thoracic, Breast, Neuroendocrine, cutaneous. #AcademicJobs #OSUCCC @osucccjames.bsky.social @christianrolfo.bsky.social

submitted 51 days ago • 0 comments

🚨 Attention oncologists & hematologists in Latin America! 🚨 Join this new Florez lab study on the implementation of exercise recommendations by physicians. Consider participating in the survey below and have your opinions heard! 💪🩺 #Oncology #Hematology #Exercise #LatinAmerica

submitted 56 days ago • 1 comment

Thanks to @narjustflorezmd.bsky.social and the #HearHer project for this awesome gift! 🙏🏽 🚨Important reminder that people who experience cancer are NOT all the same A woman or man is not “too young” to get lung cancer, same as for breast, colon, etc

submitted 54 days ago • 0 comments

Join us 2/1/25 at the Hilton Columbus at Easton @osucccjames.bsky.social Update from the #SABCS24 👋Experts from #TheJames @mskcancercenter.bsky.social #Emory will address the latest insights and practical guidance presented at #SABCS24. Register here 👉 ccme.osu.edu/continuing-m...

submitted 55 days ago • 0 comments

My take on the #Top5 🔑 studies presented at #SABCS24 for #VuMedi #bcsm #breastcancer @osucccjames.bsky.social @osuwexmed.bsky.social @sabcs.bsky.social

submitted 57 days ago • 1 comment

The Phase Ib/II trial (NCT06026657) investigates the combination of naxitamab, an anti-GD2 monoclonal antibody, gemcitabine, and TGFβ-imprinted, IL-21 expanded NK cells in HER2-negative breast cancer. Report with @drgattimays.bsky.social ( @vjoncology.bsky.social )

submitted 68 days ago • 0 comments

📣 ASCO is now here 🦋! @ascocancer.bsky.social @ascopost.bsky.social #OncSky #AcademicSky #MedSky #Oncology #CancerResearch @oncoalert.bsky.social @oncodaily.bsky.social @onclive.bsky.social

submitted 77 days ago • 3 comments

One year ago, on a sunny afternoon before the last session of #SABCS23, I stood on this balcony chatting with patient and advocate Gwen Manchion, who was stolen by MBC in the interim. This is why we do what we do.

submitted 77 days ago • 0 comments

Was great to talk to @janicetnbcmets.bsky.social about this a couple days ago —> higher doses are not always better ✨ figuring out the best fit for our pts benefits those who experience a cancer diagnosis, oncologists, as well as pharma companies. Everyone wins with this knowledge! #bcsm #SABCS24

submitted 77 days ago • 0 comments

#EMBER3 results presented @sabcs.bsky.social #SABCS24 by @breastcancerdoc.bsky.social Main take aways: 1) Imlunestrant ⬆️ PFS > SOC in 1L, ESR1 mut, mER+ BC 2) Imlunestrant + abemaciclib ⬆️ PFS in 1L mER+ BC irrespective of ESR1 or PIK3CA mut 3) Imlunestrant ⬇️ CNS progression 4) OS immature #bcsm

submitted 80 days ago • 1 comment

The best #BreastOnc team in the country in my opinion 🥰 @osuwexmed.bsky.social @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social Love where you work

submitted 78 days ago • 2 comments

So proud of new #OSU faculty member @aryaroy.bsky.social @osuwexmed.bsky.social #GoBucks @stoverlab.bsky.social @quirogad.bsky.social #GRASPAwardee

submitted 78 days ago • 1 comment

✨The best way to start the day at #SABCS24 is running the Riverwalk with @drgattimays.bsky.social @juliafoldimd.bsky.social @weoncologists.bsky.social Thanks for organizing @oncoalert.bsky.social ! #OncoAlert

submitted 79 days ago • 0 comments

Day 3 of #SABCS24 and some more great research from @osuwexmed.bsky.social faculty ##breastcancer @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social @sabcs.bsky.social

submitted 79 days ago • 0 comments

Great Wednesday agenda today at #SABCS24 @sabcs.bsky.social with lots of presentations by #OSUCCC @osuwexmed.bsky.social faculty @stoverlab.bsky.social @quirogad.bsky.social @aryaroy.bsky.social

submitted 80 days ago • 0 comments

Our newest @osucccjames.bsky.social breast med onc is hitting the ground running! 👏🏽

submitted 80 days ago • 0 comments

#OncSky #MedEd

submitted 81 days ago • 0 comments

Planning your career after fellowship? Our article on ASCO connection explores the pros & cons of academia, community & hybrid practices! A practical guide to help fellows make informed decision! @matthewkurianmd.bsky.social Rajat Thawani!

submitted 81 days ago • 1 comment

Excited for a strong showing from faculty at The James @osuwexmed.bsky.social at @sabcs.bsky.social #SABCS24 Here’s the summary I generated and will post a daily schedule of #OSUCCC presentations @stoverlab.bsky.social @aryaroy.bsky.social @quirogad.bsky.social @obeng-gyasisamilia.bsky.social

submitted 82 days ago • 0 comments

My thoughts on recent advances and remaining questions related to the use of #immunotherapy in #TNBC #bcsm #IO #VuMedi @osuwexmed.bsky.social

submitted 85 days ago • 0 comments

Smart move to include our wonderful breast med onc leader @drgattimays.bsky.social on this list 🤩 @osucccjames.bsky.social @osuwexmed.bsky.social #bcsm #OncSky

submitted 85 days ago • 0 comments

Happy holidays! 🎁🎊🎄 Kudos to @stoverlab.bsky.social for his Yuletide cheer and always putting on a great appreciation holiday breakfast for our wonderful @osucccjames.bsky.social breast center staff!

submitted 87 days ago • 0 comments

1️⃣week until SABCS and 2️⃣months until the @osucccjames.bsky.social Breast Oncology SABCS review! Featuring our ✨all-star✨ invited speakers, Drs. Kevin Kalinsky and @markrobsonmd.bsky.social Register now at: cancer.osu.edu/sabcs #bcsm #OncSky #medonc #SABCS25

submitted 87 days ago • 1 comment

Dr Ashley Davenport @osuwexmed.bsky.social discussed ways to enhance education about #breastcancer #surviorship #bcsm jnccn360.org/breast/video...

submitted 87 days ago • 0 comments

30% of the patients with cancer in our practice endorse food insecurity!! Shocking but true. Thank you #HCWvsHunger #DiagnoseAndTreats for the inspiration and motivation to be part of this effort. 🙏

submitted 90 days ago • 0 comments

We are going to be bringing #SABCS24 updates to #BlueSky too starting Dec 10th! Many great colleagues on here including some amazing advocates. @itsnotpink.bsky.social @janicetnbcmets.bsky.social @oncbrothers.bsky.social @hoperugo.bsky.social ....and others! @sabcs.bsky.social #bcsm

submitted 94 days ago • 5 comments